

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.44053486 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 7.44053486 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 7.44053486 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 7.44053486 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.44053486 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.44053486 |
| 7 | regulation of phospholipase A2 activity (GO:0032429) | 7.08620375 |
| 8 | cellular response to exogenous dsRNA (GO:0071360) | 6.30446806 |
| 9 | pinocytosis (GO:0006907) | 6.26113461 |
| 10 | microglial cell activation (GO:0001774) | 6.21451847 |
| 11 | intracellular pH reduction (GO:0051452) | 5.75614234 |
| 12 | glycosphingolipid catabolic process (GO:0046479) | 5.58103335 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 5.53823934 |
| 14 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.53123608 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.33566020 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.28565682 |
| 17 | positive regulation of mast cell degranulation (GO:0043306) | 5.24380065 |
| 18 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 5.24380065 |
| 19 | sphingolipid catabolic process (GO:0030149) | 5.23746773 |
| 20 | histamine secretion (GO:0001821) | 5.22462282 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 5.13576184 |
| 22 | membrane raft organization (GO:0031579) | 5.04865879 |
| 23 | glycolipid catabolic process (GO:0019377) | 4.99614570 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.99297939 |
| 25 | hemoglobin metabolic process (GO:0020027) | 4.97312940 |
| 26 | regulation of T cell tolerance induction (GO:0002664) | 4.93336627 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.84102712 |
| 28 | response to host immune response (GO:0052572) | 4.84102712 |
| 29 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.82380649 |
| 30 | positive regulation of type 2 immune response (GO:0002830) | 4.79841514 |
| 31 | membrane lipid catabolic process (GO:0046466) | 4.70470759 |
| 32 | T cell costimulation (GO:0031295) | 4.68895084 |
| 33 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.67220077 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 4.63841619 |
| 35 | lymphocyte costimulation (GO:0031294) | 4.63030215 |
| 36 | pH reduction (GO:0045851) | 4.54018630 |
| 37 | ceramide catabolic process (GO:0046514) | 4.52847746 |
| 38 | regulation of tolerance induction (GO:0002643) | 4.48652889 |
| 39 | iron ion import (GO:0097286) | 4.48146759 |
| 40 | positive regulation of mast cell activation (GO:0033005) | 4.41396182 |
| 41 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.39891258 |
| 42 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.39891258 |
| 43 | B cell mediated immunity (GO:0019724) | 4.30154326 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.27705132 |
| 45 | response to host (GO:0075136) | 4.27705132 |
| 46 | response to host defenses (GO:0052200) | 4.27705132 |
| 47 | membrane budding (GO:0006900) | 4.26217209 |
| 48 | import into cell (GO:0098657) | 4.15584602 |
| 49 | histamine transport (GO:0051608) | 4.13759791 |
| 50 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.11888897 |
| 51 | oligosaccharide catabolic process (GO:0009313) | 4.10150536 |
| 52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.05680900 |
| 53 | response to peptidoglycan (GO:0032494) | 4.05603015 |
| 54 | response to interferon-gamma (GO:0034341) | 4.02369280 |
| 55 | respiratory burst (GO:0045730) | 3.97902095 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 3.96529132 |
| 57 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.95845349 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.95178815 |
| 59 | cellular response to interferon-beta (GO:0035458) | 3.92245923 |
| 60 | thrombin receptor signaling pathway (GO:0070493) | 3.89700989 |
| 61 | early endosome to late endosome transport (GO:0045022) | 3.86997217 |
| 62 | positive regulation of interleukin-12 production (GO:0032735) | 3.82731692 |
| 63 | T cell receptor signaling pathway (GO:0050852) | 3.80031162 |
| 64 | response to muramyl dipeptide (GO:0032495) | 3.79263761 |
| 65 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.74262022 |
| 66 | macrophage activation (GO:0042116) | 3.72718187 |
| 67 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.70339345 |
| 68 | GPI anchor biosynthetic process (GO:0006506) | 3.66481733 |
| 69 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.65275935 |
| 70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.65091185 |
| 71 | negative regulation of B cell proliferation (GO:0030889) | 3.61422746 |
| 72 | regulation of chemokine biosynthetic process (GO:0045073) | 3.54408281 |
| 73 | grooming behavior (GO:0007625) | 3.52089538 |
| 74 | regulation of mast cell activation (GO:0033003) | 3.49855478 |
| 75 | cellular extravasation (GO:0045123) | 3.48127277 |
| 76 | I-kappaB phosphorylation (GO:0007252) | 3.46156739 |
| 77 | regulation of mast cell degranulation (GO:0043304) | 3.44602380 |
| 78 | behavioral response to ethanol (GO:0048149) | 3.41427141 |
| 79 | defense response to protozoan (GO:0042832) | 3.40863290 |
| 80 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.40447146 |
| 81 | positive regulation of interferon-gamma production (GO:0032729) | 3.39035546 |
| 82 | ribosomal large subunit biogenesis (GO:0042273) | 3.38280385 |
| 83 | membrane invagination (GO:0010324) | 3.38055864 |
| 84 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.36207261 |
| 85 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.33001160 |
| 86 | positive regulation of antigen processing and presentation (GO:0002579) | 3.32897293 |
| 87 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.32245203 |
| 88 | adenosine receptor signaling pathway (GO:0001973) | 3.32215828 |
| 89 | positive regulation of leukocyte degranulation (GO:0043302) | 3.29575170 |
| 90 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.27441974 |
| 91 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.25750955 |
| 92 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.24370590 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 3.22872207 |
| 94 | regulation of intracellular pH (GO:0051453) | 3.19697887 |
| 95 | pantothenate metabolic process (GO:0015939) | 3.19609844 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.19413205 |
| 97 | GPI anchor metabolic process (GO:0006505) | 3.17510279 |
| 98 | myeloid dendritic cell activation (GO:0001773) | 3.17209997 |
| 99 | autophagic vacuole fusion (GO:0000046) | 3.16863280 |
| 100 | positive regulation of tolerance induction (GO:0002645) | 3.13770616 |
| 101 | detection of external biotic stimulus (GO:0098581) | 3.12130506 |
| 102 | purinergic receptor signaling pathway (GO:0035587) | 3.10875321 |
| 103 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.06788751 |
| 104 | positive regulation of T cell proliferation (GO:0042102) | 3.06563847 |
| 105 | positive regulation of interleukin-17 production (GO:0032740) | 3.05053422 |
| 106 | tryptophan catabolic process (GO:0006569) | 3.04845595 |
| 107 | indole-containing compound catabolic process (GO:0042436) | 3.04845595 |
| 108 | indolalkylamine catabolic process (GO:0046218) | 3.04845595 |
| 109 | positive regulation of interferon-beta production (GO:0032728) | 3.03465631 |
| 110 | negative regulation of B cell activation (GO:0050869) | 3.01357648 |
| 111 | GTP biosynthetic process (GO:0006183) | 3.00481750 |
| 112 | cellular protein catabolic process (GO:0044257) | 2.97958013 |
| 113 | actin nucleation (GO:0045010) | 2.96408590 |
| 114 | regulation of type 2 immune response (GO:0002828) | 2.94998565 |
| 115 | kynurenine metabolic process (GO:0070189) | 2.93344324 |
| 116 | regulation of interleukin-12 production (GO:0032655) | 2.93223577 |
| 117 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93000628 |
| 118 | germinal center formation (GO:0002467) | 2.92407189 |
| 119 | positive thymic T cell selection (GO:0045059) | 2.92070663 |
| 120 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.90037402 |
| 121 | regulation of cellular pH (GO:0030641) | 2.89846344 |
| 122 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.88564550 |
| 123 | cellular response to dsRNA (GO:0071359) | 2.88400084 |
| 124 | T-helper 1 type immune response (GO:0042088) | 2.85787351 |
| 125 | response to protozoan (GO:0001562) | 2.84669593 |
| 126 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.83868645 |
| 127 | apoptotic DNA fragmentation (GO:0006309) | 2.83402042 |
| 128 | immunoglobulin mediated immune response (GO:0016064) | 2.82938938 |
| 129 | myeloid cell activation involved in immune response (GO:0002275) | 2.82677185 |
| 130 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.82586653 |
| 131 | glycoside metabolic process (GO:0016137) | 2.81380609 |
| 132 | detection of biotic stimulus (GO:0009595) | 2.80673203 |
| 133 | response to interferon-beta (GO:0035456) | 2.79817546 |
| 134 | regulation of monocyte chemotaxis (GO:0090025) | 2.76441622 |
| 135 | cellular response to interferon-gamma (GO:0071346) | 2.74697061 |
| 136 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.74417259 |
| 137 | lipid storage (GO:0019915) | 2.74235732 |
| 138 | surfactant homeostasis (GO:0043129) | 2.74230444 |
| 139 | antigen processing and presentation of peptide antigen via MHC class II (GO:0002495) | 2.73357807 |
| 140 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:000250 | 2.73357807 |
| 141 | tryptophan metabolic process (GO:0006568) | 2.73345334 |
| 142 | termination of RNA polymerase III transcription (GO:0006386) | 2.72697813 |
| 143 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.72697813 |
| 144 | positive regulation of T cell activation (GO:0050870) | 2.72624019 |
| 145 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72057686 |
| 146 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.70766056 |
| 147 | mast cell activation (GO:0045576) | 2.68535086 |
| 148 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.68381976 |
| 149 | regulation of antigen processing and presentation (GO:0002577) | 2.67965416 |
| 150 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.67300822 |
| 151 | lipoprotein metabolic process (GO:0042157) | 2.66647613 |
| 152 | positive regulation of lymphocyte proliferation (GO:0050671) | 2.65788143 |
| 153 | regulation of lymphocyte migration (GO:2000401) | 2.65245556 |
| 154 | localization within membrane (GO:0051668) | 2.64337540 |
| 155 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.64134860 |
| 156 | aromatic amino acid family catabolic process (GO:0009074) | 2.63089758 |
| 157 | positive regulation of mononuclear cell proliferation (GO:0032946) | 2.62727372 |
| 158 | regulation of T cell proliferation (GO:0042129) | 2.62646498 |
| 159 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.60552607 |
| 160 | regulation of growth of symbiont in host (GO:0044126) | 2.60552607 |
| 161 | negative regulation of growth of symbiont in host (GO:0044130) | 2.60552607 |
| 162 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.60552607 |
| 163 | cellular response to type I interferon (GO:0071357) | 2.59498916 |
| 164 | type I interferon signaling pathway (GO:0060337) | 2.59498916 |
| 165 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.59419172 |
| 166 | negative regulation of mast cell activation (GO:0033004) | 2.59178300 |
| 167 | Peyers patch development (GO:0048541) | 2.59159848 |
| 168 | phagocytosis, recognition (GO:0006910) | 2.58056016 |
| 169 | ganglioside metabolic process (GO:0001573) | 2.56496826 |
| 170 | positive regulation of macrophage cytokine production (GO:0060907) | 2.56150077 |
| 171 | response to type I interferon (GO:0034340) | 2.56066664 |
| 172 | positive regulation of T cell migration (GO:2000406) | 2.55073518 |
| 173 | cofactor transport (GO:0051181) | 2.54777072 |
| 174 | developmental programmed cell death (GO:0010623) | 2.54238776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.91242725 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.98720735 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.97404968 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.93087370 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.90494556 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.78358147 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.69507898 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.69399900 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.44044352 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.38224125 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 3.24092574 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.99008806 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92749576 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71708628 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.71444083 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.56861166 |
| 17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56153648 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.51215416 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51021639 |
| 20 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.50609472 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.24129107 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.12695846 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10845955 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.08597649 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05053343 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04876128 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 2.02194302 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93980168 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82663935 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80489108 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.78459064 |
| 32 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.75364664 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.74734172 |
| 34 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.70473138 |
| 35 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.69562871 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.69167267 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.68836494 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64546696 |
| 39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.64428259 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62732653 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62428571 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62243128 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61652827 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61490948 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55922522 |
| 46 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.55675003 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55357745 |
| 48 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53445389 |
| 49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.52590129 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49483976 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48401557 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.47215841 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43131601 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42347843 |
| 55 | AR_20517297_ChIP-Seq_VCAP_Human | 1.40980996 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35082473 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33339804 |
| 58 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32381469 |
| 59 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.31624847 |
| 60 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.31624847 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.31269426 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31010652 |
| 63 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.30750084 |
| 64 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29077080 |
| 65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28997421 |
| 66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28611303 |
| 67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28392380 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27558599 |
| 69 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26868402 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26865983 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26110027 |
| 72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25245578 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23954986 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23668132 |
| 75 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22178190 |
| 76 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.21469269 |
| 77 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18884783 |
| 78 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18884783 |
| 79 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18042695 |
| 80 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16056173 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15760556 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15760556 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14628502 |
| 84 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.14466782 |
| 85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13802935 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11716006 |
| 87 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11437014 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09488110 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08885642 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08644052 |
| 91 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07819441 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07700728 |
| 93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07700728 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07196528 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06641577 |
| 96 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.06626118 |
| 97 | MYB_26560356_Chip-Seq_TH1_Human | 1.05669222 |
| 98 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05289643 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04543980 |
| 100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03426247 |
| 101 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.02870966 |
| 102 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.02293053 |
| 103 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.02199085 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01652138 |
| 105 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.01135246 |
| 106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01059301 |
| 107 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00435724 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99260967 |
| 109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99202467 |
| 110 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98803908 |
| 111 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97798577 |
| 112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.97652326 |
| 113 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97445704 |
| 114 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96961763 |
| 115 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96696540 |
| 116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96667330 |
| 117 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96378352 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95307475 |
| 119 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93798575 |
| 120 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93625975 |
| 121 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93589966 |
| 122 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92657228 |
| 123 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.92088760 |
| 124 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91982632 |
| 125 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.91880905 |
| 126 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.91438488 |
| 127 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91392464 |
| 128 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91248554 |
| 129 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91180025 |
| 130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.89686023 |
| 131 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.89421599 |
| 132 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88784332 |
| 133 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88636605 |
| 134 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88031650 |
| 135 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.86702889 |
| 136 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.86576234 |
| 137 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86324020 |
| 138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85389980 |
| 139 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85213609 |
| 140 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.84917882 |
| 141 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.84913843 |
| 142 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84897305 |
| 143 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.84615207 |
| 144 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84466858 |
| 145 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.84039366 |
| 146 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82283909 |
| 147 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81986328 |
| 148 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80194787 |
| 149 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80194787 |
| 150 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79594585 |
| 151 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79115120 |
| 152 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79111295 |
| 153 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78733324 |
| 154 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78297270 |
| 155 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78057508 |
| 156 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.76723866 |
| 157 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.76640280 |
| 158 | UTX_26944678_Chip-Seq_JUKART_Human | 0.76240696 |
| 159 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75825366 |
| 160 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73124915 |
| 161 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.72102908 |
| 162 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70326335 |
| 163 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68764844 |
| 164 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.68558303 |
| 165 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.67858853 |
| 166 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.67212147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 5.50511357 |
| 2 | MP0004147_increased_porphyrin_level | 4.93320857 |
| 3 | MP0005360_urolithiasis | 3.50011567 |
| 4 | MP0006082_CNS_inflammation | 3.42292896 |
| 5 | MP0004510_myositis | 2.87708442 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 2.65713539 |
| 7 | MP0001853_heart_inflammation | 2.63494246 |
| 8 | MP0005671_abnormal_response_to | 2.62173594 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.56418292 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.53425895 |
| 11 | MP0000685_abnormal_immune_system | 2.53294394 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.44338563 |
| 13 | MP0009785_altered_susceptibility_to | 2.39380566 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.34440282 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.30057281 |
| 16 | MP0005387_immune_system_phenotype | 2.20156397 |
| 17 | MP0001790_abnormal_immune_system | 2.20156397 |
| 18 | MP0002419_abnormal_innate_immunity | 2.17413041 |
| 19 | MP0005025_abnormal_response_to | 2.16153133 |
| 20 | MP0003436_decreased_susceptibility_to | 2.15607682 |
| 21 | MP0003303_peritoneal_inflammation | 2.11461879 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 2.10811895 |
| 23 | MP0002090_abnormal_vision | 2.01853281 |
| 24 | * MP0002452_abnormal_antigen_presenting | 2.00444373 |
| 25 | MP0003252_abnormal_bile_duct | 1.97965973 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.96625280 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.92094695 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.83353963 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.80534222 |
| 30 | MP0009764_decreased_sensitivity_to | 1.79116078 |
| 31 | MP0001800_abnormal_humoral_immune | 1.78566164 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.77585982 |
| 33 | MP0003195_calcinosis | 1.76680987 |
| 34 | * MP0001819_abnormal_immune_cell | 1.72574128 |
| 35 | MP0005365_abnormal_bile_salt | 1.70034946 |
| 36 | MP0002723_abnormal_immune_serum | 1.66431410 |
| 37 | MP0008875_abnormal_xenobiotic_pharmacok | 1.65829898 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.65690444 |
| 39 | MP0003828_pulmonary_edema | 1.65495891 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.64837122 |
| 41 | MP0001879_abnormal_lymphatic_vessel | 1.62935552 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.62273634 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.58985207 |
| 44 | MP0000343_altered_response_to | 1.58236940 |
| 45 | MP0001958_emphysema | 1.55842396 |
| 46 | MP0004782_abnormal_surfactant_physiolog | 1.50139320 |
| 47 | MP0004142_abnormal_muscle_tone | 1.50064565 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.44477188 |
| 49 | MP0003011_delayed_dark_adaptation | 1.43104101 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.42957351 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.40876826 |
| 52 | MP0003075_altered_response_to | 1.38282314 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.32772750 |
| 54 | MP0003866_abnormal_defecation | 1.32449006 |
| 55 | MP0003045_fibrosis | 1.29458911 |
| 56 | MP0000767_abnormal_smooth_muscle | 1.29304758 |
| 57 | MP0008469_abnormal_protein_level | 1.27480547 |
| 58 | MP0009840_abnormal_foam_cell | 1.27156508 |
| 59 | MP0006054_spinal_hemorrhage | 1.25571746 |
| 60 | MP0003724_increased_susceptibility_to | 1.24503412 |
| 61 | MP0005595_abnormal_vascular_smooth | 1.23872836 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.20935484 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.20166617 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 1.18265293 |
| 65 | MP0002405_respiratory_system_inflammati | 1.17673882 |
| 66 | MP0005165_increased_susceptibility_to | 1.17362527 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.17082642 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.15204203 |
| 69 | MP0003880_abnormal_central_pattern | 1.14915321 |
| 70 | MP0004019_abnormal_vitamin_homeostasis | 1.14598840 |
| 71 | MP0005451_abnormal_body_composition | 1.13688658 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.13212802 |
| 73 | MP0000249_abnormal_blood_vessel | 1.13176117 |
| 74 | MP0005408_hypopigmentation | 1.12600140 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.11065194 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 1.10385921 |
| 77 | MP0000716_abnormal_immune_system | 1.08869266 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.08583356 |
| 79 | MP0002006_tumorigenesis | 1.08038494 |
| 80 | MP0006138_congestive_heart_failure | 1.04765275 |
| 81 | MP0002735_abnormal_chemical_nociception | 1.04539220 |
| 82 | MP0003183_abnormal_peptide_metabolism | 1.01752558 |
| 83 | MP0000609_abnormal_liver_physiology | 1.01400295 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.99505906 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.98849784 |
| 86 | MP0001663_abnormal_digestive_system | 0.98117324 |
| 87 | MP0002234_abnormal_pharynx_morphology | 0.97543686 |
| 88 | MP0000689_abnormal_spleen_morphology | 0.94714867 |
| 89 | MP0002928_abnormal_bile_duct | 0.94547857 |
| 90 | MP0002822_catalepsy | 0.94471298 |
| 91 | MP0001905_abnormal_dopamine_level | 0.94216863 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.94163505 |
| 93 | MP0005385_cardiovascular_system_phenoty | 0.91658509 |
| 94 | MP0001544_abnormal_cardiovascular_syste | 0.91658509 |
| 95 | MP0002398_abnormal_bone_marrow | 0.91041658 |
| 96 | MP0009763_increased_sensitivity_to | 0.90173777 |
| 97 | MP0005670_abnormal_white_adipose | 0.89548497 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.89145788 |
| 99 | MP0005253_abnormal_eye_physiology | 0.88649084 |
| 100 | MP0002429_abnormal_blood_cell | 0.87725292 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86690985 |
| 102 | MP0008004_abnormal_stomach_pH | 0.84243989 |
| 103 | MP0005166_decreased_susceptibility_to | 0.84016372 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.83818557 |
| 105 | MP0002972_abnormal_cardiac_muscle | 0.83082461 |
| 106 | MP0008438_abnormal_cutaneous_collagen | 0.83058098 |
| 107 | MP0001533_abnormal_skeleton_physiology | 0.81715171 |
| 108 | MP0004084_abnormal_cardiac_muscle | 0.81538093 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 0.80661065 |
| 110 | MP0000598_abnormal_liver_morphology | 0.79336783 |
| 111 | MP0001440_abnormal_grooming_behavior | 0.78402388 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.78251978 |
| 113 | MP0000371_diluted_coat_color | 0.78030723 |
| 114 | MP0003950_abnormal_plasma_membrane | 0.76982922 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.76165648 |
| 116 | MP0009697_abnormal_copulation | 0.75958724 |
| 117 | MP0008872_abnormal_physiological_respon | 0.75934306 |
| 118 | MP0001873_stomach_inflammation | 0.75615817 |
| 119 | MP0001666_abnormal_nutrient_absorption | 0.75538651 |
| 120 | MP0005075_abnormal_melanosome_morpholog | 0.75233246 |
| 121 | MP0002118_abnormal_lipid_homeostasis | 0.74823300 |
| 122 | MP0003186_abnormal_redox_activity | 0.74183641 |
| 123 | MP0008775_abnormal_heart_ventricle | 0.73234054 |
| 124 | MP0001970_abnormal_pain_threshold | 0.73011949 |
| 125 | MP0001529_abnormal_vocalization | 0.71887768 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.69424994 |
| 127 | MP0004036_abnormal_muscle_relaxation | 0.69176416 |
| 128 | MP0009643_abnormal_urine_homeostasis | 0.68286741 |
| 129 | MP0009278_abnormal_bone_marrow | 0.67217972 |
| 130 | MP0009333_abnormal_splenocyte_physiolog | 0.67147301 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.65782333 |
| 132 | MP0005535_abnormal_body_temperature | 0.65320439 |
| 133 | MP0001664_abnormal_digestion | 0.65115454 |
| 134 | MP0010630_abnormal_cardiac_muscle | 0.63921892 |
| 135 | MP0001545_abnormal_hematopoietic_system | 0.62500907 |
| 136 | MP0005397_hematopoietic_system_phenotyp | 0.62500907 |
| 137 | MP0002722_abnormal_immune_system | 0.62297569 |
| 138 | MP0000465_gastrointestinal_hemorrhage | 0.61849029 |
| 139 | MP0002733_abnormal_thermal_nociception | 0.57742633 |
| 140 | MP0004947_skin_inflammation | 0.56766500 |
| 141 | MP0002132_abnormal_respiratory_system | 0.56729891 |
| 142 | MP0002638_abnormal_pupillary_reflex | 0.55785068 |
| 143 | MP0000703_abnormal_thymus_morphology | 0.54553724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 8.18898462 |
| 2 | Cerebral palsy (HP:0100021) | 7.85724487 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 7.51115957 |
| 4 | Testicular atrophy (HP:0000029) | 6.33489214 |
| 5 | Loss of speech (HP:0002371) | 5.97299464 |
| 6 | Abnormality of complement system (HP:0005339) | 5.43857496 |
| 7 | Obstructive lung disease (HP:0006536) | 5.38792804 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 5.38792804 |
| 9 | Acrocyanosis (HP:0001063) | 4.57596519 |
| 10 | Nephritis (HP:0000123) | 4.34343386 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.26656773 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.26656773 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.26656773 |
| 14 | Arthropathy (HP:0003040) | 4.25388434 |
| 15 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.18988325 |
| 16 | Absent/shortened dynein arms (HP:0200106) | 4.18988325 |
| 17 | Recurrent abscess formation (HP:0002722) | 4.05489977 |
| 18 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 4.01819225 |
| 19 | Abnormality of the pleura (HP:0002103) | 3.97840212 |
| 20 | Hemoptysis (HP:0002105) | 3.93741172 |
| 21 | Split foot (HP:0001839) | 3.84304297 |
| 22 | Abolished electroretinogram (ERG) (HP:0000550) | 3.81146320 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 3.74979155 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.69359163 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.64989257 |
| 26 | Chronic otitis media (HP:0000389) | 3.64190058 |
| 27 | Ureteral stenosis (HP:0000071) | 3.48314998 |
| 28 | Multiple enchondromatosis (HP:0005701) | 3.28810008 |
| 29 | Mucosal telangiectasiae (HP:0100579) | 3.25122046 |
| 30 | Ureteral obstruction (HP:0006000) | 3.22108303 |
| 31 | Xerostomia (HP:0000217) | 3.16671153 |
| 32 | Emphysema (HP:0002097) | 3.13893783 |
| 33 | Vasculitis (HP:0002633) | 3.12293494 |
| 34 | Azoospermia (HP:0000027) | 3.10612053 |
| 35 | Increased serum ferritin (HP:0003281) | 3.09577584 |
| 36 | Chest pain (HP:0100749) | 3.01090676 |
| 37 | Aplastic anemia (HP:0001915) | 3.00171287 |
| 38 | Abnormality of male internal genitalia (HP:0000022) | 2.99468442 |
| 39 | Hypoproteinemia (HP:0003075) | 2.99228441 |
| 40 | Anorexia (HP:0002039) | 2.95950490 |
| 41 | Abnormality of iron homeostasis (HP:0011031) | 2.91691724 |
| 42 | Spinal cord lesions (HP:0100561) | 2.91467321 |
| 43 | Syringomyelia (HP:0003396) | 2.91467321 |
| 44 | Meningitis (HP:0001287) | 2.90817546 |
| 45 | Abnormal glucose tolerance (HP:0001952) | 2.90178609 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90087880 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90087880 |
| 48 | Skin rash (HP:0000988) | 2.89345574 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.82676152 |
| 50 | Chin dimple (HP:0010751) | 2.77364455 |
| 51 | Abnormality of the pericardium (HP:0001697) | 2.76110978 |
| 52 | Gangrene (HP:0100758) | 2.74965887 |
| 53 | Abnormality of binocular vision (HP:0011514) | 2.74103967 |
| 54 | Diplopia (HP:0000651) | 2.74103967 |
| 55 | 3-Methylglutaconic aciduria (HP:0003535) | 2.69492434 |
| 56 | Deep venous thrombosis (HP:0002625) | 2.65759745 |
| 57 | Methylmalonic acidemia (HP:0002912) | 2.65620341 |
| 58 | Hematochezia (HP:0002573) | 2.65180574 |
| 59 | Cardiomegaly (HP:0001640) | 2.61786754 |
| 60 | Poor head control (HP:0002421) | 2.60588046 |
| 61 | Glomerulopathy (HP:0100820) | 2.58926030 |
| 62 | Epistaxis (HP:0000421) | 2.54152694 |
| 63 | Abnormality of macrophages (HP:0004311) | 2.53235664 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.50027357 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 2.48644775 |
| 66 | Myocardial infarction (HP:0001658) | 2.48629418 |
| 67 | Apathy (HP:0000741) | 2.48325244 |
| 68 | Restrictive lung disease (HP:0002091) | 2.48284385 |
| 69 | Paralysis (HP:0003470) | 2.48117273 |
| 70 | Recurrent skin infections (HP:0001581) | 2.47668946 |
| 71 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.47235049 |
| 72 | Macular degeneration (HP:0000608) | 2.45119110 |
| 73 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.44696886 |
| 74 | Polycythemia (HP:0001901) | 2.37105020 |
| 75 | Absent frontal sinuses (HP:0002688) | 2.36487411 |
| 76 | Cheilitis (HP:0100825) | 2.36300661 |
| 77 | Amyloidosis (HP:0011034) | 2.35576861 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.34829480 |
| 79 | Diminished motivation (HP:0000745) | 2.34470037 |
| 80 | Ascites (HP:0001541) | 2.34449893 |
| 81 | Abnormal ciliary motility (HP:0012262) | 2.33217238 |
| 82 | Progressive visual loss (HP:0000529) | 2.32801111 |
| 83 | Increased IgM level (HP:0003496) | 2.31370800 |
| 84 | Polyneuropathy (HP:0001271) | 2.30166383 |
| 85 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.29317546 |
| 86 | Short 1st metacarpal (HP:0010034) | 2.29317546 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.28733344 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.27405745 |
| 89 | Recurrent sinusitis (HP:0011108) | 2.25912346 |
| 90 | Xanthomatosis (HP:0000991) | 2.25857674 |
| 91 | Enlarged epiphyses (HP:0010580) | 2.25481420 |
| 92 | Mitral stenosis (HP:0001718) | 2.25165723 |
| 93 | Constricted visual fields (HP:0001133) | 2.24502797 |
| 94 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22741675 |
| 95 | Hepatocellular necrosis (HP:0001404) | 2.21938126 |
| 96 | Progressive microcephaly (HP:0000253) | 2.21152574 |
| 97 | Ankyloglossia (HP:0010296) | 2.19188533 |
| 98 | Granulocytopenia (HP:0001913) | 2.19106802 |
| 99 | Interstitial pulmonary disease (HP:0006530) | 2.18961565 |
| 100 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.17613949 |
| 101 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.17613949 |
| 102 | Acute necrotizing encephalopathy (HP:0006965) | 2.14836135 |
| 103 | Neoplasm of the colon (HP:0100273) | 2.12917372 |
| 104 | Abnormality of B cell number (HP:0010975) | 2.12694951 |
| 105 | Radial bowing (HP:0002986) | 2.10041311 |
| 106 | Mitochondrial inheritance (HP:0001427) | 2.10026260 |
| 107 | Abnormality of the 1st metacarpal (HP:0010009) | 2.09448623 |
| 108 | Abnormal spermatogenesis (HP:0008669) | 2.08681244 |
| 109 | Eosinophilia (HP:0001880) | 2.07256607 |
| 110 | Increased hepatocellular lipid droplets (HP:0006565) | 2.05329452 |
| 111 | Congenital, generalized hypertrichosis (HP:0004540) | 2.05083475 |
| 112 | Paresthesia (HP:0003401) | 2.04945080 |
| 113 | Urticaria (HP:0001025) | 2.04610638 |
| 114 | Prolonged partial thromboplastin time (HP:0003645) | 2.04066543 |
| 115 | Recurrent fungal infections (HP:0002841) | 2.03777622 |
| 116 | Joint hemorrhage (HP:0005261) | 2.03202250 |
| 117 | Median cleft lip (HP:0000161) | 2.02154256 |
| 118 | Amaurosis fugax (HP:0100576) | 1.99623941 |
| 119 | Nasal polyposis (HP:0100582) | 1.99509264 |
| 120 | Exertional dyspnea (HP:0002875) | 1.98310832 |
| 121 | Vacuolated lymphocytes (HP:0001922) | 1.97638913 |
| 122 | Hematuria (HP:0000790) | 1.96686466 |
| 123 | Hypercholesterolemia (HP:0003124) | 1.95582991 |
| 124 | Pancreatitis (HP:0001733) | 1.95498230 |
| 125 | Complement deficiency (HP:0004431) | 1.95285559 |
| 126 | Intrahepatic cholestasis (HP:0001406) | 1.94587140 |
| 127 | Esophageal varix (HP:0002040) | 1.94540541 |
| 128 | Increased CSF lactate (HP:0002490) | 1.94495216 |
| 129 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.94360788 |
| 130 | Pruritus (HP:0000989) | 1.94339317 |
| 131 | Hyperlipoproteinemia (HP:0010980) | 1.94089502 |
| 132 | Abnormality of methionine metabolism (HP:0010901) | 1.91599993 |
| 133 | Colitis (HP:0002583) | 1.89838371 |
| 134 | Mediastinal lymphadenopathy (HP:0100721) | 1.89689020 |
| 135 | Gingival bleeding (HP:0000225) | 1.89350133 |
| 136 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88415257 |
| 137 | Gastrointestinal infarctions (HP:0005244) | 1.88395439 |
| 138 | Amelogenesis imperfecta (HP:0000705) | 1.87105353 |
| 139 | Myotonia (HP:0002486) | 1.86731291 |
| 140 | Progressive macrocephaly (HP:0004481) | 1.86471016 |
| 141 | Pulmonary fibrosis (HP:0002206) | 1.86279737 |
| 142 | Thrombophlebitis (HP:0004418) | 1.85285161 |
| 143 | Recurrent viral infections (HP:0004429) | 1.84726565 |
| 144 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.84715791 |
| 145 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.84643909 |
| 146 | Cerebral hemorrhage (HP:0001342) | 1.82310827 |
| 147 | Methylmalonic aciduria (HP:0012120) | 1.81410315 |
| 148 | Distal arthrogryposis (HP:0005684) | 1.80738346 |
| 149 | Gingivitis (HP:0000230) | 1.80519893 |
| 150 | Stomatitis (HP:0010280) | 1.78583591 |
| 151 | Epidermoid cyst (HP:0200040) | 1.77943679 |
| 152 | Fatigue (HP:0012378) | 1.77287764 |
| 153 | Cleft eyelid (HP:0000625) | 1.76648827 |
| 154 | Short phalanx of the thumb (HP:0009660) | 1.76584662 |
| 155 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.76279150 |
| 156 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.73057294 |
| 157 | Pulmonary embolism (HP:0002204) | 1.71477881 |
| 158 | Abnormality of the prostate (HP:0008775) | 1.70015233 |
| 159 | Vertigo (HP:0002321) | 1.69459137 |
| 160 | Hypertensive crisis (HP:0100735) | 1.68218823 |
| 161 | Metaphyseal dysplasia (HP:0100255) | 1.66843770 |
| 162 | Generalized hyperpigmentation (HP:0007440) | 1.66585368 |
| 163 | Myositis (HP:0100614) | 1.65302086 |
| 164 | J-shaped sella turcica (HP:0002680) | 1.64677807 |
| 165 | Arterial thrombosis (HP:0004420) | 1.63947468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.85556853 |
| 2 | EIF2AK3 | 4.18337085 |
| 3 | STK16 | 3.98832227 |
| 4 | TAOK2 | 3.61317063 |
| 5 | MAP3K12 | 3.40483394 |
| 6 | CSF1R | 3.22968748 |
| 7 | TBK1 | 3.03467001 |
| 8 | TYK2 | 3.02693819 |
| 9 | MAP3K14 | 2.87757716 |
| 10 | TIE1 | 2.63124402 |
| 11 | KIT | 2.47047073 |
| 12 | IRAK3 | 2.38864394 |
| 13 | NUAK1 | 2.35114436 |
| 14 | TLK1 | 2.32496760 |
| 15 | MAP4K2 | 2.27505886 |
| 16 | IRAK4 | 2.27244610 |
| 17 | FLT3 | 2.23317515 |
| 18 | GRK1 | 2.20541429 |
| 19 | FGFR4 | 2.20422681 |
| 20 | EPHB1 | 2.14859124 |
| 21 | CSK | 1.99913332 |
| 22 | BMPR1B | 1.92930813 |
| 23 | MYLK | 1.89380224 |
| 24 | KDR | 1.87804890 |
| 25 | PIK3CG | 1.86983776 |
| 26 | IKBKB | 1.84987690 |
| 27 | TAOK3 | 1.75996006 |
| 28 | BLK | 1.72484025 |
| 29 | JAK1 | 1.68046915 |
| 30 | SYK | 1.53889724 |
| 31 | STK24 | 1.50352024 |
| 32 | MAP2K3 | 1.48635492 |
| 33 | PRKG2 | 1.40499229 |
| 34 | MAP3K5 | 1.38872765 |
| 35 | TGFBR2 | 1.38650578 |
| 36 | JAK3 | 1.33532783 |
| 37 | FRK | 1.33372633 |
| 38 | MAP2K6 | 1.28969714 |
| 39 | TEC | 1.27253042 |
| 40 | FGFR3 | 1.26351437 |
| 41 | NEK9 | 1.16631049 |
| 42 | RIPK1 | 1.15091718 |
| 43 | IKBKE | 1.13790044 |
| 44 | MAPKAPK3 | 1.07356902 |
| 45 | ERN1 | 1.05044418 |
| 46 | FES | 1.04942812 |
| 47 | ITK | 1.00305449 |
| 48 | PDK1 | 0.99478076 |
| 49 | TXK | 0.98003163 |
| 50 | EPHA3 | 0.97800727 |
| 51 | LYN | 0.95692693 |
| 52 | ILK | 0.95265058 |
| 53 | RPS6KB2 | 0.94575994 |
| 54 | SCYL2 | 0.92562413 |
| 55 | MAP3K8 | 0.91648118 |
| 56 | LRRK2 | 0.86460104 |
| 57 | HCK | 0.86358444 |
| 58 | DAPK1 | 0.85841639 |
| 59 | MATK | 0.81126569 |
| 60 | RPS6KA4 | 0.80393935 |
| 61 | ZAK | 0.79189658 |
| 62 | STK10 | 0.77924267 |
| 63 | ADRBK2 | 0.76764145 |
| 64 | ZAP70 | 0.76502920 |
| 65 | JAK2 | 0.76043308 |
| 66 | EIF2AK2 | 0.75939896 |
| 67 | PRKCE | 0.74703450 |
| 68 | PDPK1 | 0.73261919 |
| 69 | RPS6KA5 | 0.70528416 |
| 70 | DMPK | 0.69642173 |
| 71 | PKN1 | 0.68963182 |
| 72 | INSRR | 0.67735935 |
| 73 | CLK1 | 0.67107083 |
| 74 | PAK4 | 0.66871211 |
| 75 | MAP3K11 | 0.66641308 |
| 76 | PRKCQ | 0.64866362 |
| 77 | MST4 | 0.64688673 |
| 78 | RIPK4 | 0.63656115 |
| 79 | TNK2 | 0.63539988 |
| 80 | MAP3K3 | 0.62821433 |
| 81 | PTK6 | 0.61114803 |
| 82 | PRKCD | 0.60524473 |
| 83 | STK3 | 0.60280386 |
| 84 | PIM1 | 0.60259067 |
| 85 | RPS6KA6 | 0.60171403 |
| 86 | CHUK | 0.60082913 |
| 87 | BMPR2 | 0.60040695 |
| 88 | STK11 | 0.58547934 |
| 89 | STK4 | 0.57418106 |
| 90 | BTK | 0.56589342 |
| 91 | FGR | 0.56460754 |
| 92 | TTN | 0.54697624 |
| 93 | EGFR | 0.53572264 |
| 94 | CSNK1A1L | 0.53271148 |
| 95 | LCK | 0.51020961 |
| 96 | ABL1 | 0.50649621 |
| 97 | VRK1 | 0.49764755 |
| 98 | OBSCN | 0.49558261 |
| 99 | BMX | 0.49295682 |
| 100 | GRK6 | 0.47722505 |
| 101 | EIF2AK1 | 0.47599815 |
| 102 | MAP3K6 | 0.46253539 |
| 103 | CDK19 | 0.44955378 |
| 104 | PTK2B | 0.44386384 |
| 105 | PRKAA2 | 0.43369022 |
| 106 | CDK8 | 0.43314503 |
| 107 | DAPK2 | 0.42438859 |
| 108 | RPS6KC1 | 0.42272516 |
| 109 | RPS6KL1 | 0.42272516 |
| 110 | HIPK2 | 0.41437907 |
| 111 | SIK3 | 0.40908919 |
| 112 | BCKDK | 0.39440388 |
| 113 | MARK3 | 0.39228269 |
| 114 | PINK1 | 0.37714379 |
| 115 | MAP3K13 | 0.36917307 |
| 116 | TRIB3 | 0.36779553 |
| 117 | ABL2 | 0.36668731 |
| 118 | RPS6KA2 | 0.36659243 |
| 119 | MAPKAPK5 | 0.34912859 |
| 120 | PRKD1 | 0.34684576 |
| 121 | VRK2 | 0.34683345 |
| 122 | DAPK3 | 0.34180114 |
| 123 | ERBB2 | 0.31198193 |
| 124 | IGF1R | 0.31039031 |
| 125 | NME2 | 0.30988091 |
| 126 | GRK7 | 0.30937188 |
| 127 | PBK | 0.30353966 |
| 128 | ERBB3 | 0.30073956 |
| 129 | PKN2 | 0.29993859 |
| 130 | CAMK1 | 0.28854893 |
| 131 | CAMKK2 | 0.28178305 |
| 132 | MAP3K2 | 0.28107401 |
| 133 | MAPK11 | 0.28001987 |
| 134 | DYRK1B | 0.26980513 |
| 135 | CSNK1G3 | 0.26749822 |
| 136 | TAOK1 | 0.26715107 |
| 137 | SIK1 | 0.25146345 |
| 138 | STK38L | 0.24780530 |
| 139 | TGFBR1 | 0.23871276 |
| 140 | CSNK1G2 | 0.22990795 |
| 141 | MAPK4 | 0.21916696 |
| 142 | OXSR1 | 0.21545887 |
| 143 | MAPKAPK2 | 0.21530085 |
| 144 | CSNK2A1 | 0.20687896 |
| 145 | IRAK1 | 0.20649291 |
| 146 | MAPK13 | 0.20416614 |
| 147 | PRKCB | 0.20077196 |
| 148 | MAPK7 | 0.19482129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 6.30723396 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 5.48152741 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 5.18268429 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.63183116 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.50641028 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.41434063 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.15211608 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75306475 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52526528 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42685094 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.40927701 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.09820064 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09092718 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.08998318 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.05939912 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02696182 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01234719 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.80939939 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79787960 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76133632 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.60347553 |
| 22 | ABC transporters_Homo sapiens_hsa02010 | 1.58500546 |
| 23 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.49908973 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43806973 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42430623 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41378114 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40071836 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32645588 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32095393 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26334522 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.24872268 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.22140851 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.21845001 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21792233 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.21762628 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.21588624 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.20010143 |
| 38 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.19450595 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.17916276 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17614296 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16374254 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15920412 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15723711 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.13038193 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12659895 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.11395902 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11360925 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.09716605 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06952226 |
| 50 | Protein export_Homo sapiens_hsa03060 | 1.06854513 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.05716381 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03044827 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.02666420 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.01866731 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.01836243 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.00773129 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 1.00158938 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.97819112 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.95675336 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.95214350 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95055213 |
| 62 | Ribosome_Homo sapiens_hsa03010 | 0.93322520 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.92102506 |
| 64 | Measles_Homo sapiens_hsa05162 | 0.89746233 |
| 65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89590765 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88567421 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87715965 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86966942 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.85894513 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85397711 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81963242 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77098774 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73724633 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73683580 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72183991 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71992169 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71519110 |
| 78 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71303773 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71019902 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69762598 |
| 81 | RNA polymerase_Homo sapiens_hsa03020 | 0.69246734 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68586413 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66091750 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.66045752 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65164304 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62080000 |
| 87 | Proteasome_Homo sapiens_hsa03050 | 0.56894371 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56228606 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56068438 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.55086238 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52884516 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.51131097 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51108718 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50693884 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49941472 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.49939706 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49664861 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48211011 |
| 99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47827338 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.46988355 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46271520 |
| 102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45663680 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45433323 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42346480 |
| 105 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41353596 |
| 106 | Olfactory transduction_Homo sapiens_hsa04740 | 0.38928574 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.38760631 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.38537848 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.38127118 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | 0.37710668 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37065399 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36657621 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36585612 |
| 114 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.35823400 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35818926 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35569254 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34598040 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.33793554 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31119936 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30224541 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29407733 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28663309 |
| 123 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28250432 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26990119 |
| 125 | Huntingtons disease_Homo sapiens_hsa05016 | 0.25791666 |
| 126 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25642602 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24212629 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.22195649 |
| 129 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.21858147 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21650252 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20038119 |
| 132 | Phototransduction_Homo sapiens_hsa04744 | 0.18089600 |
| 133 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.16003013 |
| 134 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14657312 |
| 135 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12302956 |
| 136 | Renin secretion_Homo sapiens_hsa04924 | 0.12045658 |
| 137 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.09537651 |
| 138 | RNA degradation_Homo sapiens_hsa03018 | 0.08272203 |
| 139 | Taste transduction_Homo sapiens_hsa04742 | 0.05152399 |
| 140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03940688 |
| 141 | Circadian entrainment_Homo sapiens_hsa04713 | 0.03055443 |
| 142 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.00149347 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | -0.0756459 |
| 144 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0615895 |
| 145 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | -0.0596712 |
| 146 | Morphine addiction_Homo sapiens_hsa05032 | -0.0194980 |
| 147 | Purine metabolism_Homo sapiens_hsa00230 | -0.0080117 |
| 148 | Calcium signaling pathway_Homo sapiens_hsa04020 | -0.0019047 |

